{"id":"https://openalex.org/W7225402136","doi":"https://doi.org/10.3389/fmicb.2026.2002454","title":"A glycosylation-associated hemagglutinin substitution improves the breadth of an influenza B mRNA vaccine","display_name":"A glycosylation-associated hemagglutinin substitution improves the breadth of an influenza B mRNA vaccine","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225402136","doi":"https://doi.org/10.3389/fmicb.2026.2002454"},"language":"en","primary_location":{"id":"doi:10.3389/fmicb.2026.2002454","doi":"https://doi.org/10.3389/fmicb.2026.2002454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.2002454","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.2002454/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.2002454/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5125419121","display_name":"Ziqi Cheng","orcid":"https://orcid.org/0009-0007-3097-8156","observed_orcids":["https://orcid.org/0009-0007-3097-8156"]},"institutions":[{"id":"https://openalex.org/I223893228","display_name":"National Medical Products Administration","ror":"https://ror.org/002k3wk88","country_code":"CN","type":"government","lineage":["https://openalex.org/I223893228","https://openalex.org/I4405258220"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ziqi Cheng","raw_affiliation_strings":["Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals","Division of Monoclonal Antibody Products, National Institutes for Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals","institution_ids":[]},{"raw_affiliation_string":"Division of Monoclonal Antibody Products, National Institutes for Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products","institution_ids":["https://openalex.org/I223893228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161102059","display_name":"Yeqing Sun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yeqing Sun","raw_affiliation_strings":["Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125420325","display_name":"Yunbo Bai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yunbo Bai","raw_affiliation_strings":["Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161084999","display_name":"Lan Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223893228","display_name":"National Medical Products Administration","ror":"https://ror.org/002k3wk88","country_code":"CN","type":"government","lineage":["https://openalex.org/I223893228","https://openalex.org/I4405258220"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lan Wang","raw_affiliation_strings":["Division of Monoclonal Antibody Products, National Institutes for Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Monoclonal Antibody Products, National Institutes for Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products","institution_ids":["https://openalex.org/I223893228"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160036957","display_name":"Chenyan Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chenyan Zhao","raw_affiliation_strings":["Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS and Sexually-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Drug Control, WHO Collaborating Center for Standardization and Evaluation of Biologicals","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5160036957","https://openalex.org/A5161084999"],"corresponding_institution_ids":["https://openalex.org/I223893228"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/influenza-b","display_name":"influenza B","score":0.972000002861023},{"id":"https://openalex.org/keywords/hemagglutinin","display_name":"hemagglutinin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/glycosylation","display_name":"glycosylation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/b-victoria-lineage","display_name":"B/Victoria lineage","score":0.8320000171661377},{"id":"https://openalex.org/keywords/b-yamagata-lineage","display_name":"B/Yamagata lineage","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cross-neutralization","display_name":"cross-neutralization","score":0.7799999713897705},{"id":"https://openalex.org/keywords/mrna-vaccines","display_name":"mRNA vaccines","score":0.9049999713897705},{"id":"https://openalex.org/keywords/antigenic-modification","display_name":"antigenic modification","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7627000212669373},{"id":"https://openalex.org/C2780115692","wikidata":"https://www.wikidata.org/wiki/Q5747302","display_name":"Heterologous","level":3,"score":0.7342000007629395},{"id":"https://openalex.org/C2778692840","wikidata":"https://www.wikidata.org/wiki/Q9136673","display_name":"Hemagglutinin (influenza)","level":3,"score":0.7170000076293945},{"id":"https://openalex.org/C7842527","wikidata":"https://www.wikidata.org/wiki/Q575258","display_name":"Antigenic drift","level":4,"score":0.6929000020027161},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6805999875068665},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.6473000049591064},{"id":"https://openalex.org/C2780689484","wikidata":"https://www.wikidata.org/wiki/Q383260","display_name":"Influenza vaccine","level":3,"score":0.6151999831199646},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5503000020980835},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4546999931335449},{"id":"https://openalex.org/C2778022156","wikidata":"https://www.wikidata.org/wiki/Q576145","display_name":"Strain (injury)","level":2,"score":0.43939998745918274},{"id":"https://openalex.org/C2777546802","wikidata":"https://www.wikidata.org/wiki/Q834390","display_name":"Influenza A virus","level":3,"score":0.42340001463890076},{"id":"https://openalex.org/C86282344","wikidata":"https://www.wikidata.org/wiki/Q575314","display_name":"Antigenic shift","level":5,"score":0.4221999943256378},{"id":"https://openalex.org/C82988372","wikidata":"https://www.wikidata.org/wiki/Q5628866","display_name":"H5N1 genetic structure","level":5,"score":0.3935999870300293},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3573000133037567},{"id":"https://openalex.org/C2778220771","wikidata":"https://www.wikidata.org/wiki/Q1522579","display_name":"Substitution (logic)","level":2,"score":0.35179999470710754},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3452000021934509},{"id":"https://openalex.org/C191942190","wikidata":"https://www.wikidata.org/wiki/Q4774739","display_name":"Antigenic variation","level":3,"score":0.3183000087738037},{"id":"https://openalex.org/C180915046","wikidata":"https://www.wikidata.org/wiki/Q575264","display_name":"Original antigenic sin","level":5,"score":0.31790000200271606},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.3070000112056732},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.2863999903202057},{"id":"https://openalex.org/C2781416681","wikidata":"https://www.wikidata.org/wiki/Q287246","display_name":"Orthomyxoviridae","level":4,"score":0.28060001134872437},{"id":"https://openalex.org/C2780441014","wikidata":"https://www.wikidata.org/wiki/Q7907952","display_name":"Vaccine efficacy","level":3,"score":0.27140000462532043},{"id":"https://openalex.org/C2993683473","wikidata":"https://www.wikidata.org/wiki/Q30693176","display_name":"Amino acid substitution","level":4,"score":0.26499998569488525},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.250900000333786},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2508000135421753}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fmicb.2026.2002454","doi":"https://doi.org/10.3389/fmicb.2026.2002454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.2002454","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.2002454/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:332e3c7d7a1148e2bcb7c06135a9a381","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/332e3c7d7a1148e2bcb7c06135a9a381","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Microbiology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmicb.2026.2002454","doi":"https://doi.org/10.3389/fmicb.2026.2002454","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.2002454","pdf_url":"https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2026.2002454/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322919","display_name":"Natural Science Foundation of Beijing Municipality","ror":null},{"id":"https://openalex.org/F4320335657","display_name":"State Key Laboratory of Drug Research","ror":"https://ror.org/058t7w767"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225402136.pdf","grobid_xml":"https://content.openalex.org/works/W7225402136.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2055030676","https://openalex.org/W2062665189","https://openalex.org/W2087770333","https://openalex.org/W2102335249","https://openalex.org/W2104391453","https://openalex.org/W2127852419","https://openalex.org/W2141469436","https://openalex.org/W2148828011","https://openalex.org/W2157764725","https://openalex.org/W2162177682","https://openalex.org/W2795740139","https://openalex.org/W2898906782","https://openalex.org/W2918139290","https://openalex.org/W3043431476","https://openalex.org/W3082685454","https://openalex.org/W3088823112","https://openalex.org/W3117591467","https://openalex.org/W4396833930","https://openalex.org/W4399182385","https://openalex.org/W4401175326","https://openalex.org/W4407641622"],"related_works":["https://openalex.org/W4407641622","https://openalex.org/W7160625841","https://openalex.org/W4409698157","https://openalex.org/W4293084911","https://openalex.org/W2904951290","https://openalex.org/W7143283473","https://openalex.org/W2043409632","https://openalex.org/W4406235361","https://openalex.org/W2767495920","https://openalex.org/W4310251723"],"abstract_inverted_index":{"Introduction":[0],"Influenza":[1],"B":[2,21,54,181],"virus":[3],"is":[4],"an":[5,96],"important":[6],"cause":[7],"of":[8,52,71,152,177],"seasonal":[9],"influenza,":[10],"with":[11,148,161],"its":[12],"contribution":[13],"varying":[14],"across":[15],"regions":[16],"and":[17,32,108,137],"seasons.":[18],"Historically,":[19],"influenza":[20,53,180],"viruses":[22,38,164],"have":[23,39],"been":[24,40],"classified":[25],"into":[26,120],"two":[27],"major":[28],"lineages:":[29],"B/Victoria":[30,112],"(BV)":[31],"B/Yamagata.":[33],"No":[34],"naturally":[35],"circulating":[36],"B/Yamagata-lineage":[37],"confirmed":[41],"after":[42],"March":[43],"2020,":[44],"making":[45],"protection":[46,103],"against":[47,141],"BV":[48],"the":[49,63,68,79,84,89,101,111,117,132,142,153,162,175],"current":[50],"priority":[51],"vaccination.":[55],"In":[56],"our":[57],"previous":[58],"study,":[59],"we":[60],"demonstrated":[61],"that":[62],"T214A":[64],"mutation":[65],"significantly":[66],"alters":[67],"cross-neutralization":[69],"capacity":[70],"this":[72],"antigen,":[73],"potentially":[74],"through":[75],"altered":[76],"glycosylation.":[77],"Notably,":[78],"WHO-recommended":[80],"vaccine":[81,155],"strain":[82],"for":[83,174],"season,":[85],"B/Austria/1359417/2021":[86],"(BV21),":[87],"lacked":[88],"relevant":[90],"glycosylation":[91,133],"position.":[92],"Methods":[93],"We":[94,114],"used":[95],"mRNA":[97],"platform":[98],"to":[99],"compare":[100],"cross-subclade":[102],"provided":[104],"by":[105],"B/Wyoming/06/2014":[106],"(BW06)":[107],"BV21":[109,121,136],"within":[110],"lineage.":[113],"also":[115],"introduced":[116],"D212N":[118,129],"substitution":[119,130],"as":[122],"a":[123,149],"minimal":[124],"antigenic":[125],"modification.":[126],"Results":[127],"The":[128],"restored":[131],"motif":[134],"in":[135],"enhanced":[138],"cross-neutralizing":[139],"responses":[140],"tested":[143,163],"heterologous":[144],"strains.":[145],"Mice":[146],"immunized":[147],"high":[150],"dose":[151],"D212N-modified":[154],"showed":[156],"100%":[157],"survival":[158],"following":[159],"challenge":[160],"from":[165],"different":[166],"subclades.":[167],"Discussion":[168],"Our":[169],"findings":[170],"provide":[171],"valuable":[172],"insights":[173],"development":[176],"broadly":[178],"protective":[179],"vaccines.":[182]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}